Related references
Note: Only part of the references are listed.The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew et al.
JOURNAL OF RHEUMATOLOGY (2022)
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis
Luca Navarini et al.
SCIENTIFIC REPORTS (2022)
Are Differences in Inflammatory Markers between Patients with and without Hypertension-Mediated Organ Damage Influenced by Circadian Blood Pressure Abnormalities?
Nestor Vazquez-Agra et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors
Aicha Ben Tekaya et al.
RMD OPEN (2022)
Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
J. David Spence et al.
HYPERTENSION (2022)
High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a Long-term follow-up study
Lin-Hong Shi et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2022)
Assessment of arterial stiffness and epicardial adipose tissue thickness in predicting the subclinical atherosclerosis in patients with ankylosing spondylitis
Kenan Demir et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2021)
Diagnostic delay in axial spondyloarthritis: a systematic review and meta-analysis
Sizheng Steven Zhao et al.
RHEUMATOLOGY (2021)
Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis
Jean W. Liew et al.
ARTHRITIS CARE & RESEARCH (2020)
Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis
Sizheng Steven Zhao et al.
RHEUMATOLOGY (2020)
Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study
Mohammad H. Derakhshan et al.
JOURNAL OF RHEUMATOLOGY (2019)
Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
Jonas K. Eriksson et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs
Tilo Grosser et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Endothelial Progenitor Cells as a Marker of Endothelial Dysfunction and Atherosclerosis in Ankylosing Spondylitis: A Cross-Sectional Study
Inderjeet Verma et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2017)
A Test in Context High-Sensitivity C-Reactive Protein
Paul M. Ridker
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study
Nisha Nigil Haroon et al.
ANNALS OF INTERNAL MEDICINE (2015)
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Alper M. van Sijl et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Pathophysiology of hypertension: interactions between macro and microvascular alterations through endothelial dysfunction
Alexandra Yannoutsos et al.
JOURNAL OF HYPERTENSION (2014)
The effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis-a randomized, placebo-controlled pilot trial
Lai-Shan Tam et al.
RHEUMATOLOGY (2014)
A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis
C-H Chou et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2014)
Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: A cross-sectional study
Inger Jorid Berg et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
No Increased Rate of Acute Myocardial Infarction or Stroke Among Patients with Ankylosing Spondylitis-A Retrospective Cohort Study Using Routine Data
Sinead Brophy et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment
Pal Soltesz et al.
AUTOIMMUNITY REVIEWS (2011)
Population-Based Estimates of Common Comorbidities and Cardiovascular Disease in Ankylosing Spondylitis
Ann Bremander et al.
ARTHRITIS CARE & RESEARCH (2011)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor a blockade
I. C. van Eijk et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Global burden of blood-pressure-related disease, 2001
Carlene M. M. Lawes et al.
LANCET (2008)
Cardiovascular risk profile of patients with psoriatic arthritis compared to controlsthe role of inflammation
L. -S. Tam et al.
RHEUMATOLOGY (2008)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Christopher P. Cannon et al.
LANCET (2006)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Renin expression in COX-2-knockout mice on normal or low-salt diets
TX Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Share Paper
